Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus.
about
Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV diseaseThe association of health-related quality of life with survival among persons with HIV infection in the United States.Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world
P2860
Changes in surrogate laboratory markers, clinical endpoints, and health-related quality of life in patients infected with the human immunodeficiency virus.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Changes in surrogate laborator ...... human immunodeficiency virus.
@ast
Changes in surrogate laborator ...... human immunodeficiency virus.
@en
Changes in surrogate laborator ...... human immunodeficiency virus.
@nl
type
label
Changes in surrogate laborator ...... human immunodeficiency virus.
@ast
Changes in surrogate laborator ...... human immunodeficiency virus.
@en
Changes in surrogate laborator ...... human immunodeficiency virus.
@nl
prefLabel
Changes in surrogate laborator ...... human immunodeficiency virus.
@ast
Changes in surrogate laborator ...... human immunodeficiency virus.
@en
Changes in surrogate laborator ...... human immunodeficiency virus.
@nl
P2860
P1476
Changes in surrogate laborator ...... human immunodeficiency virus.
@en
P2093
P2860
P304
P356
10.1177/016327879802100207
P577
1998-06-01T00:00:00Z